Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
DNA (Ginkgo Bioworks Holdings, Inc.) has 3 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: TWST +2.26%, in healthcare.
183 institutional managers report a position in Ginkgo Bioworks Holdings, Inc. worth $368.4M between them, filed on form 13F for the quarter ending 2026-06-30. 23 of them hold 80% of it, the largest being BlackRock, Inc. at 11.52%.
158 more managers in the register
23 managers hold 80% of the $368.4M institutional base. The other 160 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Viking Global Investors LP, Tudor Investment Corp ET AL, Allianz Asset Management AG · 9.62% of DNA, 18.45% of ADPT
via Baillie Gifford & Co, Viking Global Investors LP, Allianz Asset Management AG · 6.43% of DNA, 5.79% of RACE
via Viking Global Investors LP · 9.62% of DNA, 18.77% of TIC
via Viking Global Investors LP · 9.62% of DNA, 19.83% of LAB
via Viking Global Investors LP · 9.62% of DNA, 8.12% of INBX
via Baillie Gifford & Co, Viking Global Investors LP · 6.43% of DNA, 9.72% of SE
Managers holding a meaningful stake in DNA also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
Ginkgo Bioworks Holdings, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Biological Products, (No Diagnostic Substances)
Prev close 6.99 · gapped below the open, then crossed back over prior close. High/low 7.13 at 11:30 am ET, 6.84 at 4:00 am ET.